XJSE
RHB
Market cap6mUSD
May 22, Last price
180.00ZAR
1D
-0.55%
1Q
28.57%
IPO
-82.35%
Name
RH BOPHELO LIMITED
Chart & Performance
P/E
63.75
P/S
40.88
EPS
2.82
Div Yield, %
—
Shrs. gr., 5y
4.90%
Rev. gr., 5y
63.35%
Revenues
285m
+3,735.27%
Net income
183m
P
CFO
-34m
L
Dividend
Dec 12, 202331 ZAR/sh
Earnings
May 26, 2025
Profile
RH Bophelo Limited invests in healthcare sector in South Africa. It primarily invests in equity, quasi-equity, and equity related investments in operational infrastructure, including health insurance, private hospital-related infrastructure, pharmaceuticals, and retail and distribution sectors. The company was incorporated in 2016 and is based in Johannesburg, South Africa. RH Bophelo Limited is a subsidiary of Public Investment Corporation SOC Limited.
Valuation
Title ZAR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2024‑02 | 2023‑02 | 2022‑02 | 2021‑02 | 2020‑02 | 2019‑02 | 2018‑02 | 2017‑02 | |
| Income | ||||||||
Revenues | 284,856 3,735.27% | 7,427 -75.16% | ||||||
Cost of revenue | 12,273 | 5,526 | ||||||
Unusual Expense (Income) | ||||||||
NOPBT | 272,583 | 1,901 | ||||||
NOPBT Margin | 95.69% | 25.59% | ||||||
Operating Taxes | 49,568 | (12,397) | ||||||
Tax Rate | 18.18% | |||||||
NOPAT | 223,015 | 14,297 | ||||||
Net income | 182,644 -666.99% | (32,213) -160.23% | ||||||
Dividends | (20,054) | |||||||
Dividend yield | 7.77% | |||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | 22,578 | 103,320 | ||||||
Long-term debt | 52,308 | 3,729 | ||||||
Deferred revenue | (561) | |||||||
Other long-term liabilities | 561 | |||||||
Net debt | (1,072,868) | (861,326) | ||||||
| Cash flow | ||||||||
Cash from operating activities | (33,831) | 10,283 | ||||||
CAPEX | (80) | (46) | ||||||
Cash from investing activities | (12,358) | 34,784 | ||||||
Cash from financing activities | (51,011) | 99,100 | ||||||
FCF | 211,072 | 5,305 | ||||||
| Balance | ||||||||
Cash | 54,730 | 151,930 | ||||||
Long term investments | 1,093,024 | 816,445 | ||||||
Excess cash | 1,133,511 | 968,004 | ||||||
Stockholders' equity | 1,034,333 | 871,744 | ||||||
Invested Capital | 73,439 | 104,692 | ||||||
ROIC | 250.39% | 26.56% | ||||||
ROCE | 22.46% | 0.18% | ||||||
| EV | ||||||||
Common stock shares outstanding | 64,691 | 64,691 | ||||||
Price | 3.99 | |||||||
Market cap | 258,118 | |||||||
EV | (814,749) | |||||||
EBITDA | 273,492 | 2,790 | ||||||
EV/EBITDA | ||||||||
Interest | 20,114 | 7,033 | ||||||
Interest/NOPBT | 7.38% | 369.99% | ||||||